The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Subscribe To Our Newsletter & Stay Updated
